Welcome to LookChem.com Sign In|Join Free

CAS

  • or

132194-31-1

Post Buying Request

132194-31-1 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

132194-31-1 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 132194-31-1 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,3,2,1,9 and 4 respectively; the second part has 2 digits, 3 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 132194-31:
(8*1)+(7*3)+(6*2)+(5*1)+(4*9)+(3*4)+(2*3)+(1*1)=101
101 % 10 = 1
So 132194-31-1 is a valid CAS Registry Number.
InChI:InChI=1/C24H28N2O4/c1-29-24-15-19(27)9-10-22(24)26-13-11-25(12-14-26)16-20(28)17-30-23-8-4-6-18-5-2-3-7-21(18)23/h2-10,15,20,27-28H,11-14,16-17H2,1H3

132194-31-1SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 14, 2017

Revision Date: Aug 14, 2017

1.Identification

1.1 GHS Product identifier

Product name 4-[4-(2-hydroxy-3-naphthalen-1-yloxypropyl)piperazin-1-yl]-3-methoxyphenol

1.2 Other means of identification

Product number -
Other names 4-Hydroxyphenylnaftodipil

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:132194-31-1 SDS

132194-31-1Downstream Products

132194-31-1Relevant articles and documents

Synthesis of potential Naftopidil metabolites

Kutscher,Engel,Fleischhauer,Niebch

, p. 803 - 806 (2007/10/02)

The synthesis of four proposed metabolites 1-4 of Naftopidil, a selective α1-antagonist, is reported. These compounds comprise hydroxylated and demethylated derivatives and a cleavage product of Naftopidil.

Piperazine derivatives, uses thereof and pharmaceutical compositions containing them

-

, (2008/06/13)

The present invention provides compounds of the general formula: STR1 wherein R1 is a hydroxyl group or a methoxy radical, R2 is a hydrogen atom or a hyroxyl group and R3 is a hydrogen atom or a hydroxyl group, with the proviso that R2 and R3 are not simultaneously hydrogen atoms when R1 is a methoxy radical; and the pharmacologically acceptable salts thereof. The present invention also provides processes for the preparation of these compounds and pharmaceutical compositions containing them.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 132194-31-1